With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.203714-71-0,Dichloro(2-isopropoxyphenylmethylene)(tricyclohexylphosphine)ruthenium (II),as a common compound, the synthetic route is as follows.
NHC ligand precursor 10 (156 mg, .3 mmol), KOz-Bu(F g) (66 mg, .3 mmol), and ruthenium complex 11 (132 mg, .22 mmol) were all combined in toluene in a glove box. The flask was removed and stirred at 60 0C for 18 hours in a fume hood. The reaction mixture was then directly purified by flash column chromatography (5% Et2theta/Hexanes, run 2 times) to yield catalyst 12 (34 mg, 20%) as a green oil. The catalyst was then lyophilized from benzene to give a pale green solid. It should be noted that by 1H NMR the conversion to 12 is 50%. 1H NMR (300 MHz, CDCl3) delta 16.91 (IH, s), 8.14-8.13 (2H, m), 7.73 (2H, m), 7.64 (IH, m), 7.52 (IH, m), 7.06-6.92 (2H, m), 6.62 (IH, t, J = 7.5 Hz), 6.31 (IH, d, J – 8.4 Hz), 4.47 (IH, quint, J = 6 Hz), 3.51 (4H, s), 1.51 (18H, s), 1.35 (6H, d, J = 6 Hz), 1.24 (18H, s); HRMS (EI+) calc for C4IH58N2OCl2Ru 766.2970. Found 766.3007. Fig. 4 depicts the single crystal X-ray structure was obtained for catalyst 12.
The synthetic route of 203714-71-0 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; MATERIA, INC.; CALIFORNIA INSTITUTE OF TECHNOLOGY; WO2007/75427; (2007); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI